Page last updated: 2024-10-22

amifostine anhydrous and B-Cell Chronic Lymphocytic Leukemia

amifostine anhydrous has been researched along with B-Cell Chronic Lymphocytic Leukemia in 4 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research Excerpts

ExcerptRelevanceReference
" In conclusion, the individualized protocol of fludarabine combined with rituximab and amifostine showed the safety and effectiveness for treatment of aged patient with CLL."1.34[Curative efficacy of fludarabine combined with rituximab and amifostine on aged patient with B-chronic lymphocytic leukemia]. ( Li, SX; Liu, Y; Lu, XC; Zhu, HL, 2007)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giles, FJ1
Shi, GG1
Cortes, JE1
Thomas, D1
Keating, AR1
Kantarjian, HM1
Keating, MJ1
O'Brien, SM1
Tsatalas, C1
Spanoudakis, E1
Pantelidou, D1
Margaritis, D1
Kotsianidis, I1
Chalkia, P1
Tripsianis, G1
Basdiara, I1
Kartasis, Z1
Karakolios, A1
Bourikas, G1
Liu, Y1
Zhu, HL1
Lu, XC1
Li, SX1
Coia, L1
Krigel, R1
Hanks, G1
Comis, R1
Algazy, K1
Peters, R1
McCulloch, W1
Schien, P1

Trials

2 trials available for amifostine anhydrous and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia.
    Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:3

    Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Leukem

2003
A phase I study of WR-2721 in combination with total body irradiation (TBI) in patients with refractory lymphoid malignancies.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:4

    Topics: Amifostine; Combined Modality Therapy; Drug Evaluation; Humans; Leukemia, Lymphocytic, Chronic, B-Ce

1992

Other Studies

2 other studies available for amifostine anhydrous and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Amifostine stimulates the formation of hematopoietic bone marrow progenitors from B-cell chronic lymphocytic leukemia.
    Acta haematologica, 2004, Volume: 112, Issue:3

    Topics: Aged; Aged, 80 and over; Amifostine; Bone Marrow; Cell Division; Female; Hematopoiesis; Hematopoieti

2004
[Curative efficacy of fludarabine combined with rituximab and amifostine on aged patient with B-chronic lymphocytic leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2007, Volume: 15, Issue:5

    Topics: Aged; Amifostine; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Com

2007